Weitz Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$24.5M |
| 2 |
Danaher
DHR
|
+$12.9M |
| 3 |
IDEX
IEX
|
+$10.5M |
| 4 |
SiriusXM
SIRI
|
+$5.19M |
| 5 |
Equifax
EFX
|
+$3.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$20.8M |
| 2 |
Roper Technologies
ROP
|
+$19.3M |
| 3 |
Guidewire Software
GWRE
|
+$17.7M |
| 4 |
Fidelity National Information Services
FIS
|
+$12.1M |
| 5 |
VeriSign
VRSN
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.33% |
| 2 | Communication Services | 17.3% |
| 3 | Technology | 15.76% |
| 4 | Industrials | 14.44% |
| 5 | Healthcare | 12.21% |
Similar funds
Weitz Investment Management's Q4 2024 Portfolio in Review
As of Q4 2024, Weitz Investment Management held 50 positions worth $1.94B, down 4.4% from $2.03B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Weitz Investment Management withdrew a net $75.1M in Q4 2024, closing 3 positions and reducing 16 holdings. Its most notable exit was Microchip Technology, an estimated $20.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Communication Services and Technology.
Against the trend, Weitz Investment Management added an estimated $24.5M to Bio-Techne.
- Weitz Investment Management added most to Bio-Techne in Q4 2024, an estimated $24.5M increase.
- Weitz Investment Management's biggest Q4 2024 reduction was Roper Technologies, cutting an estimated $19.3M.
- Weitz Investment Management fully exited Microchip Technology in Q4 2024, selling an estimated $20.8M.
- Weitz Investment Management's ten largest holdings make up 48% of its $1.94B portfolio in Q4 2024.
- Weitz Investment Management opened 0 new positions and closed 3 in Q4 2024.
- Weitz Investment Management's portfolio value fell 4.4% quarter-over-quarter to $1.94B.
Based on Weitz Investment Management's 13F filing for Q4 2024, filed 12 Feb 2025.